Skip to main content
. 2022 Jul 13;42(28):5499–5509. doi: 10.1523/JNEUROSCI.2397-21.2022

Table 1.

IC50 Values for PMP inhibition of KARs

Receptor IC50 mean (µm) (SD) Confidence interval (µm) p Value
GluK1 19 ± 5.3 13–33
GluK2 26 ± 9.8 17–56
GluK3 41 ± 5.7 34–56
GluK1/GluK5 2.8 ± 0.32 2.2–3.5 <0.0001a
GluK2/GluK5 0.85 ± 0.09 0.69–1.0 <0.0001a
GluK3/GluK5 14 ± 7.5 7.3–37 0.03a
GluK1/Neto1 11 ± 4.1 6.9–23 0.13a
GluK1/Neto2 19 ± 4.3 13–29 0.94a
GluK2/Neto1 5.4 ± 0.94 3.9–7.6 <0.0001a
GluK2/Neto2 5.8 ± 0.84 4.4–7.7 <0.0001a
GluK1/GluK5/Neto2 0.99 ± 0.15 0.73–1.3 <0.0001b
GluK2/GluK5/Neto1 0.69 ± 0.16 0.45–1.1 0.001b
GluK2(N557D) 2.8 ± 0.32 2.2–3.5 <0.0001c
GluK2(N557D)/GluK5 1.1 ± 0.28 0.72–1.8 0.19c
GluK2/GluK5(D540N) 3.0 ± 0.43 2.3–4.0 <0.0001c
GluA4(i) 0.56 ± 0.12 0.36–0.85 0.51d
DRG neurons 11 ± 1.0 9.4–13
Mossy fiber EPSCKAR 2.9 ± 0.76 1.9–4.9

Statistical comparisons between IC50 values derived from best fits to the inhibition-response data were made pairwise using the extra sum-of-squares F test.

aHeteromeric receptors compared against their homomeric counterparts.

bNeto-containing heteromeric receptors compared against their Neto-less counterparts.

cMutant receptors compared against their wild-type counterparts.

dGluA4(i) AMPA receptors compared against GluK2/GluK5/Neto1 KARs.